ANI Pharmaceuticals reported $211.37M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
AbbVie USD 15.42B 2.08B Jun/2025
ANI Pharmaceuticals USD 211.37M 14.27M Jun/2025
Aurora Cannabis CAD 98.02M 9.82M Jun/2025
Canopy Growth CAD 72.13M 2.63M Jun/2025
Eli Lilly USD 15.56B 2.83B Jun/2025
Hikma Pharmaceutical USD 1.59B 18M Dec/2024
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Novartis USD 14.84B 1.28B Jun/2025
Perrigo USD 1.06B 20M Jun/2025
Sun Pharmaceuticals INR 138.51B 8.92B Jun/2025
Teva Pharmaceutical Industries USD 14.06B 0 Jun/2025